Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 1,290 shares of common stock at a price of $6.3725 per share on June 17, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On June 17, 2024, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc. (HCAT), sold 1,290 shares of the company's common stock.
- The sale was executed at a price of $6.3725 per share.
- Following the transaction, Llewelyn directly owns 121,154 shares of Health Catalyst common stock.
- The sale was conducted under a pre-arranged trading plan adopted on May 23, 2023, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.
Key Dates
| Date | Description |
|---|---|
| May 23, 2023 | Date the Reporting Person adopted a written trading plan in accordance with Rule 10b5-1 |
| June 17, 2024 | Date of the transaction (stock sale) |
| June 20, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.